Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route. [electronic resource]
Producer: 20170322Description: 53-62 p. digitalISSN:- 1432-1831
- Adjuvants, Immunologic -- administration & dosage
- Administration, Intranasal
- Animals
- Antibodies, Protozoan -- blood
- Cholera Toxin -- administration & dosage
- Cytokines -- metabolism
- Disease Models, Animal
- Female
- Immunity, Mucosal
- Immunoglobulin A -- analysis
- Immunoglobulin G -- blood
- Injections, Subcutaneous
- Mice, Inbred CBA
- Oleic Acids -- administration & dosage
- Poly I-C -- administration & dosage
- Protein Serine-Threonine Kinases -- genetics
- Protozoan Proteins
- Protozoan Vaccines -- administration & dosage
- Recombinant Proteins -- genetics
- Th1 Cells -- immunology
- Th2 Cells -- immunology
- Toxoplasmosis -- prevention & control
- Treatment Outcome
- Vaccines, DNA -- administration & dosage
- Vaccines, Subunit -- administration & dosage
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.